Effect of cigarette smoking on CYP2C9 activity.

被引：2
|
作者：
Kim, M
LaCourse, J
Nafziger, AN
Wallace, AL
Kashuba, AD
Rowland, E
Gaedigk, A
Bertino, JS
机构：
[1] Bassett Healthcare, Cooperstown, NY USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Childrens Mercy Hosp, Cooperstown, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90407-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P14 / P14
页数：1
相关论文
共 50 条
  • [31] The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variations
    Kirac, Deniz
    Yaman, Aysun Erdem
    Doran, Tansu
    Altunok, Elif Cigdem
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 209 - 213
  • [32] Repeated PMR is characterized by small intra-subject day to day variability in CYP2C9 activity.
    Caraco, Y
    Kraselnikov, I
    Wood, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P37 - P37
  • [33] Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance
    Shaul, Chanan
    Blotnick, Simcha
    Adar, Liat
    Muszkat, Mordechai
    Bialer, Meir
    Caraco, Yoseph
    CLINICAL PHARMACOKINETICS, 2022, 61 (08) : 1187 - 1198
  • [34] Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: Effect on atypical, kinetic metabolism profiles
    Tracy, TS
    Hutzler, JM
    Haining, RL
    Rettie, AI
    Hummel, MA
    Dickman, LJ
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (04) : 385 - 390
  • [35] Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance
    Chanan Shaul
    Simcha Blotnick
    Liat Adar
    Mordechai Muszkat
    Meir Bialer
    Yoseph Caraco
    Clinical Pharmacokinetics, 2022, 61 : 1187 - 1198
  • [36] CYP2C9 ACTIVITY IN TURKISH PATIENTS WITH RHEUMATOID ARTHRITIS
    Ozer, E. K.
    Albayrak, I.
    Goktas, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 965 - 966
  • [37] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
  • [38] Post-PCR detection and discrimination of the CYP2C9*1, CYP2C9*2, and CYP2C9*3 SNPs using gene probes.
    Goldford, M
    Backus, J
    Triscott, M
    CLINICAL CHEMISTRY, 2000, 46 (11) : 1878 - 1878
  • [39] Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9☆59
    Dai, Da-Peng
    Wang, Shuang-Hu
    Li, Chuan-Bao
    Geng, Pei-Wu
    Cai, Jie
    Wang, Hao
    Hu, Guo-Xin
    Cai, Jian-Ping
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (08) : 1246 - 1249
  • [40] Enzymatic activity of 38 CYP2C9 genotypes on ibuprofen
    Yuan, Ling-jing
    Li, Xiang-yu
    Ye, Feng
    Li, Xin-yue
    Li, Qing-qing
    Zhong, Yun-shan
    Wang, Shi-yu
    Wang, Ya-hui
    Hu, Guo-xin
    Cai, Jian-ping
    Li, Jun-wei
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 178
12345